Lv2
180 积分 2023-05-07 加入
老年2型糖尿病患者DPP-4i多重用药安全 管理专家共识(2026版）
2个月前
已完结
Cardiovascular event reduction among a US population eligible for semaglutide per the SELECT trial
3个月前
已完结
Demystifying Obesity: Understanding, Prevention, Treatment, and Stigmas
4个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
7个月前
已完结
皖公网安备34019202002308
